MedTrace Logo

SAW Lung Microbiome Study in Smokers and Never-smokers

NCT03562442 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-04-17

No results posted yet for this study

Summary

The trial aims to analyse changes in the microbiome of the lower airways after smoking cessation. Microbiome analyses (upper airway swabs, bronchoalveolar lavage, transbronchial brushing) are conducted in smokers before and 6 weeks after smoking cessation. Never smokers serve as a control group and undergo the same sampling procedures once.

Conditions

  • Smoking Cessation
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Healthy
  • Microbial Colonization

Interventions

BEHAVIORAL

Smoking cessation

Smoking cessation with or without professional / medical support

Sponsors & Collaborators

  • Research Center Borstel

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-29
Primary Completion
2019-12-31
Completion
2020-03-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03562442 on ClinicalTrials.gov